Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Minna Marttila-Vaara"'
Autor:
Antti Hurme, Pinja Jalkanen, Minna Marttila-Vaara, Jemna Heroum, Heidi Jokinen, Saimi Vara, Oona Liedes, Johanna Lempainen, Merit Melin, Ilkka Julkunen, Leena Kainulainen
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Primary antibody deficiencies, such as common variable immunodeficiency (CVID), are heterogenous disease entities consisting of primary hypogammaglobulinemia and impaired antibody responses to vaccination and natural infection. CVID is the most commo
Externí odkaz:
https://doaj.org/article/cf14b535be11405fa6025bf0759a239d
Autor:
Gisela Schott, Yolanda V Martinez, R. Erandie Ediriweera de Silva, Anna Renom-Guiteras, Anna Vögele, David Reeves, Ilkka Kunnamo, Minna Marttila-Vaara, Andreas Sönnichsen
Publikováno v:
BMC Geriatrics, Vol 17, Iss S1, Pp 11-39 (2017)
Abstract Background Preventable drug-related hospital admissions can be associated with drugs used in diabetes and the benefits of strict diabetes control may not outweigh the risks, especially in older populations. The aim of this study was to look
Externí odkaz:
https://doaj.org/article/4977bf03f0a94029be13d84acec62a78
Autor:
Johanna Vilhonen, Mari Kanerva, Taru Finnilä, Annukka Pietikäinen, Päivi Jalava-Karvinen, Laura Airas, Juha Puustinen, Jukka Hytönen, Anneli Lauhio, Tony Häggblom, Mari Koivisto, Saija Hurme, Ulla Hohenthal, Elisa Kortela, Minna Marttila-Vaara, Jarmo Oksi, Tuomas Nieminen
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 72(8)
Background Lyme neuroborreliosis (LNB) is often treated with intravenous ceftriaxone even if doxycycline is suggested to be noninferior to ceftriaxone. We evaluated the efficacy of oral doxycycline in comparison to ceftriaxone in the treatment of LNB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e3a8c1208a11ae2fb0fde3f7faa2d84
https://pubmed.ncbi.nlm.nih.gov/32133487
https://pubmed.ncbi.nlm.nih.gov/32133487
Autor:
Anna Vögele, Yolanda V Martinez, Minna Marttila-Vaara, Ilkka Kunnamo, Gisela Schott, Anna Renom-Guiteras, R. Erandie Ediriweera de Silva, Andreas Sönnichsen, David Reeves
Publikováno v:
BMC Geriatrics
Schott, G, Martinez, Y V, Ediriweera De Silva, R E, Renom-guiteras, A, Vögele, A, Reeves, D, Kunnamo, I, Marttila-vaara, M & Sönnichsen, A 2017, ' Effectiveness and safety of dipeptidyl peptidase 4 inhibitors in the management of type 2 diabetes in older adults: a systematic review and development of recommendations to reduce inappropriate prescribing ', BMC Geriatrics, vol. 17, no. S1 . https://doi.org/10.1186/s12877-017-0571-8
BMC Geriatrics, Vol 17, Iss S1, Pp 11-39 (2017)
Schott, G, Martinez, Y V, Ediriweera De Silva, R E, Renom-guiteras, A, Vögele, A, Reeves, D, Kunnamo, I, Marttila-vaara, M & Sönnichsen, A 2017, ' Effectiveness and safety of dipeptidyl peptidase 4 inhibitors in the management of type 2 diabetes in older adults: a systematic review and development of recommendations to reduce inappropriate prescribing ', BMC Geriatrics, vol. 17, no. S1 . https://doi.org/10.1186/s12877-017-0571-8
BMC Geriatrics, Vol 17, Iss S1, Pp 11-39 (2017)
BACKGROUND: Preventable drug-related hospital admissions can be associated with drugs used in diabetes and the benefits of strict diabetes control may not outweigh the risks, especially in older populations. The aim of this study was to look for evid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef851d52dfb7dc1a7f7bc5bdc346b208
https://doi.org/10.1186/s12877-017-0571-8
https://doi.org/10.1186/s12877-017-0571-8